Soucacos Panayotis N, Johnson Elizabeth O, Babis George
Department of Orthopaedic Surgery, University of Athens, School of Medicine, Athens, Greece.
Injury. 2008 Sep;39 Suppl 2:S1-4. doi: 10.1016/S0020-1383(08)70009-3.
Bone loss from trauma, neoplasia, reconstructive surgery and congenital defects remains a major health problem, making the development of effective bone regeneration therapies a primary priority. The long-term clinical goal is to reconstruct bony tissue in an anatomically functional three-dimensional morphology. Today, the science of bone regeneration is in its infancy with current and emerging therapies still having significant limitations. In addition to bone grafting, current bone regeneration strategies include the application of different bioactive factors, cell types, biologic or artificial scaffolds, alone or in various combinations. Recently, efforts are focused more on understanding the normal bone regenerative process where multiple factors interact in a defined temporal and spatial cascade of events. Bone biology has benefited over the last decade from an explosion of information regarding the molecular mechanisms underlying bone formation and resorption, as well as the feedback signals controlling these complex homeostatic mechanisms. New insights in the complexity of the homeostatic mechanisms regulating bone remodeling have uncovered potential therapeutic strategies for bone repair.
创伤、肿瘤、重建手术和先天性缺陷导致的骨质流失仍然是一个重大的健康问题,因此开发有效的骨再生疗法成为首要任务。长期的临床目标是重建具有解剖学功能的三维形态的骨组织。如今,骨再生科学尚处于起步阶段,当前和新兴的疗法仍存在显著局限性。除了骨移植,目前的骨再生策略还包括单独或多种组合应用不同的生物活性因子、细胞类型、生物或人工支架。最近,人们更多地致力于了解正常的骨再生过程,在这个过程中,多种因素在特定的时间和空间事件级联中相互作用。在过去十年中,骨生物学受益于有关骨形成和吸收的分子机制以及控制这些复杂稳态机制的反馈信号的大量信息。对调节骨重塑的稳态机制复杂性的新见解揭示了骨修复的潜在治疗策略。